Bio-Rad Laboratories, Inc.
BIO
Classifica tra le azioni
#2168
Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules,... Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.
Prezzo delle azioni
$352.07
Ultima sincronizzazione: 2026-10-19
Capitalizzazione di mercato
$9.41B
Variazione (1 giorno)
-0.23%
Variazione (1 anno)
9.37%
Paese
US
Scambia Bio-Rad Laboratories, Inc. (BIO)
Categoria
Healthcare
Utile per Bio-Rad Laboratories, Inc. (BIO)
Utile nel Jun 2026 TTM: $350.40M
Secondo gli ultimi rapporti finanziari di Bio-Rad Laboratories, Inc., gli utili attuali della società sono $350.40M. Nel 2024, la società ha registrato un utile di $-2.34B, una diminuzione rispetto a agli utili del 2023, che erano di $-850.10M. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di Bio-Rad Laboratories, Inc. dal 2000 al 2026
Utile alla fine di ogni anno
| Anno | Utile | Cambia |
|---|---|---|
| 2026 (TTM) | $350.40M | -64.80% |
| 2025 | $995.50M | -142.50% |
| 2024 | $-2.34B | 175.55% |
| 2023 | $-850.10M | -81.93% |
| 2022 | $-4.70B | -186.33% |
| 2021 | $5.45B | 10.80% |
| 2020 | $4.92B | 117.51% |
| 2019 | $2.26B | 345.66% |
| 2018 | $507.36M | 418.75% |
| 2017 | $97.81M | 135.33% |
| 2016 | $41.56M | -71.50% |
| 2015 | $145.85M | 10.86% |
| 2014 | $131.56M | 17.06% |
| 2013 | $112.39M | -51.47% |
| 2012 | $231.58M | -1.77% |
| 2011 | $235.76M | 7.03% |
| 2010 | $220.28M | 18.54% |
| 2009 | $185.83M | 30.10% |
| 2008 | $142.84M | 18.21% |
| 2007 | $120.84M | -14.92% |
| 2006 | $142.03M | 52.11% |
| 2005 | $93.37M | -4.06% |
| 2004 | $97.33M | -14.39% |
| 2003 | $113.69M | 8.89% |
| 2002 | $104.41M | 60.70% |
| 2001 | $64.97M | 42.97% |
| 2000 | $45.44M | 0.00% |
Utile per aziende simili o concorrenti
| Azienda | Utile | Differenza negli utili | Il paese |
|---|---|---|---|
| $7.51B | 2,043.55% |
US
|
|
| $5.56B | 1,487.61% |
IE
|
|
| $5.15B | 1,369.18% |
US
|
|
| $3.86B | 1,001.88% |
US
|
|
| - | - |
DE
|
